RE: 💥 HOTTEST STOCK ON AIM💥 - 10 RNSs in two days of pure buyers13 Jul 2024 18:17
Back to TopSkip to main content
U.S. flagAn official website of the United States governmentHere's how you know
NIH NLM LogoLog in
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Logo of traumamonthly
Trauma Mon. 2016 Feb; 21(1): e26023. Published online 2016 Feb 6. doi: 10.5812/traumamon.26023
PMCID: PMC4869418PMID: 27218055
Overview of Agents Used for Emergency Hemostasis
Hadi Khoshmohabat,1 Shahram Paydar,2,3 Hossein Mohammad Kazemi,1 and Behnam Dalfardi1,2,*
Author information Article notes Copyright and License information PMC Disclaimer
Go to:
Abstract
Context:
In today’s modern world, despite the multiple advances made in the field of medicine, hemorrhagic shock is still the main cause of battlefield mortality and the second most prevalent cause of mortality in civilian trauma. Hemostatic agents can play a key role in establishing hemostasis in prehospital situations and preventing hemorrhage-associated death. In this respect, this article aims to review different aspects of known hemostatic agents